ADVANTEST (6857) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Against a backdrop of expanding semiconductor testing demand for AI and HPC applications, the Test Systems Business led substantial increases in both revenue and earnings. Revenue was ¥367.47B (+39.3% YoY), Operating Income was ¥189.99B (+53.3%), and Net Income was ¥174.78B (+93.8%). The Operating Margin improved to 51.7% from 47.0% in the same period of the previous year. However, Financial Income of ¥44.68B, including ¥41.08B in fair-value gains on financial instruments related to strategic investments, contributed to the sharp increase in Net Income. Accordingly, both business growth and temporary valuation gains boosted performance, which should be taken into consideration.

Factors Affecting Performance

【Revenue】Revenue increased +39.3% YoY to ¥367.47B. The core Test Systems Business grew +38.7% to ¥333.56B, primarily driven by expanding demand for both SoC and memory testers for AI and HPC applications. Services and Others also grew +46.0%.

【Profit and Loss】Operating Income increased +53.3% to ¥189.99B. Both the gross margin, at 69.5% versus 65.1% in the previous year, and the Operating Margin, at 51.7% versus 47.0%, improved, resulting in earnings growth exceeding revenue growth. Net Income increased +93.8% to ¥174.78B; however, the ¥41.08B valuation gain included in Financial Income was a temporary factor, and the difference between Net Income growth and Profit Before Tax growth (+92.9%) was primarily attributable to this valuation gain. In conclusion, the Company achieved increases in both revenue and earnings.

Segment Analysis

The Test Systems Business is the core business, accounting for 90.8% of the revenue mix. Its unadjusted Operating Income increased +50.3% YoY to ¥190.72B, with a 57.2% margin, driving overall performance. Services and Others accounted for 9.2% of the revenue mix and recorded unadjusted Operating Income of ¥8.56B, with a 25.3% margin and +216.4% YoY growth. However, the same period of the previous year included a ¥2.50B gain on the partial transfer of a business, meaning that the comparative basis contributed to the reported earnings growth rate. The 31.9-point difference in margins between the two segments is substantial, indicating that the equipment-sales-focused Test Systems Business is the core source of profitability.

Key Financial Metrics

Profitability: ROE (Annualized) 67.1%, Operating Margin 51.7% (47.0% in the previous year)
Cash Flow Quality: Operating Cash Flow (OCF)/Net Income 0.78x, Free Cash Flow ¥34.61B
Investment Efficiency: Capital expenditures of ¥9.85B and depreciation and amortization expense of ¥7.15B, or 1.4x, indicating a growth investment phase
Financial Soundness: Equity Ratio 68.8% (67.9% in the previous year), Current Ratio 266.6%

Cash Flow Analysis

Operating Cash Flow was ¥137.15B, equivalent to 0.78x Net Income, representing a substantial +192.7% increase from the same period of the previous year. Investing Cash Flow was an outflow of ¥102.55B, primarily due to the acquisition of investment securities totaling ¥87.82B, in addition to ¥9.85B in capital expenditures. Financing Cash Flow was an inflow of ¥34.97B, as the ¥100.0B issuance of convertible bonds exceeded shareholder returns consisting of ¥21.43B in dividends and ¥42.21B in share repurchases. Free Cash Flow was ¥34.61B. The OCF/Net Income ratio was below 1.0x due to an increase in inventories of ¥41.35B and corporate income tax payments of ¥101.11B. Accordingly, the assessment of cash generation warrants somewhat greater than standard caution.

Earnings Quality

Recurring business earnings power is reflected in the 51.7% Operating Margin. Corporate income taxes of ¥59.30B separate Profit Before Tax of ¥234.08B from Net Income of ¥174.78B. Financial Income of ¥44.68B was equivalent to 12.2% of revenue, and more than 90% of this amount, or ¥41.08B, consisted of fair-value gains on financial instruments related to strategic investments, a temporary factor. The fact that OCF was below Net Income, at 0.78x, should be noted from an accrual perspective, with the increase in inventories being the primary factor.

Earnings Forecast and Guidance

Q1 progress against the full-year forecast (Revenue ¥171.40B, Operating Income ¥84.60B, Net Income ¥66.00B) was 21.4% for Revenue, 22.5% for Operating Income, and 26.5% for Net Income. Compared with the standard progress rate of 25%, Revenue and Operating Income were somewhat below plan, consistent with the back-loaded pattern of semiconductor capital expenditures in the second half of the year. The upside in Net Income progress was significantly affected by fair-value gains on financial instruments and should be distinguished from actual headroom against the full-year plan. Following an upward revision to the CY26 tester market outlook, the Company raised its full-year forecast from the April outlook by ¥29.40B for Revenue and ¥21.85B for Operating Income.

Shareholder Returns

Q1 dividend payments were ¥21.43B, resulting in a Payout Ratio of 12.3% against Net Income of ¥174.78B. Including ¥42.21B in share repurchases, total shareholder returns of ¥63.64B resulted in a Total Return Ratio of 36.4%. Free Cash Flow of ¥34.61B covered dividends by 1.6x, although total shareholder returns exceeded FCF. With cash and cash equivalents of ¥413.12B and an Equity Ratio of 68.8%, the Company has a strong financial foundation and maintained the capacity to execute shareholder returns during the quarter.

Catalysts

【Short Term】Trends in orders for SoC and memory testers from Q2 onward, the progress of inventory absorption following the ¥41.35B increase in inventories, and whether progress against the full-year forecast accelerates. 【Long Term】Progress in expanding production capacity following the upward revision of the CY26 tester market (TAM) outlook to $13.0–14.5B, execution of the ¥11.00B R&D investment plan, and the sustainability of demand accompanying increasing complexity in AI semiconductors.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability is substantially above the manufacturing-industry median, placing the Company among the top performers within the industry.

Growth and Capital Efficiency

The growth rate also significantly exceeds the manufacturing-industry median, indicating that the Company is strongly benefiting from AI-related demand.

※Source: Compiled by the Company

Risk Factors

1. Inventory accumulation risk: Inventories increased +18.1% YoY to ¥273.65B, reaching 223 days of annualized inventory turnover and a CCC of 142 days. A reversal in the semiconductor capital expenditure cycle could lead to valuation losses and lower utilization rates.

2. Demand cycle dependence risk: The Test Systems Business, which accounts for 90.8% of revenue, is highly dependent on semiconductor investment trends for AI and HPC applications. A slowdown in investment could significantly affect both revenue and margins.

3. Financial asset price volatility risk: Investment securities increased to ¥357.74B, accounting for 23.6% of total assets. In Q1, fair-value changes of ¥120.23B through OCI and valuation gains of ¥41.08B recognized in profit or loss were recorded, creating a structure in which market fluctuations can readily affect Net Income and net assets.

Key Earnings Takeaways

1. The Operating Margin of 51.7% and gross margin of 69.5% both improved from the previous year, resulting in earnings growth exceeding revenue growth. Improvements in product mix and fixed-cost absorption contributed, demonstrating the structural strength of the Company’s business competitiveness.

2. Net Income growth (+93.8%) included ¥41.08B in valuation gains on strategic investments, and the difference from Operating Income growth (+53.3%) was primarily attributable to this temporary factor. For evaluating core earnings power, it is useful to prioritize Operating Income and OCF.

3. The increase in inventories and extension of the CCC are the reverse side of working capital tied up during a growth investment phase. Future inventory absorption and order trends will determine the sustainability of cash-generating capacity.

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,717–¥3,961 for Cost of Equity ±1%; ¥3,755–¥3,961 for ω ±0.1.

Notes:

• The EPS impact of approximately ¥27.3 per share resulting from a ±¥5 fluctuation in the assumed exchange rate has been reflected in the bear/bull scenarios.
• Because forecast ROE is high, ROE is capped at 50% for calculation purposes (differences between scenarios may therefore appear small).
• Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated values based solely on publicly disclosed data; these figures are not forecasts of the market price or recommendations for any specific investment action and do not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through an integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---